The news is by your side.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.


NEW YORK, March 12, 2019 — Rowley Law PLLC is investigating potential claims against Osiris Therapeutics, Inc. (NASDAQ: OSIR) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Smith & Nephew plc. Stockholders will receive $19.00 for each share of Osiris Therapeutics, Inc. stock that they hold. The transaction is valued at approximately $660.5 million and is expected to close in the second quarter of 2019.

If you are a stockholder of Osiris Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit

Related Posts
1 of 59,792

Attorney Advertising. Prior results do not guarantee a similar outcome.


Related Links

Comments are closed.